Difficulty: Medium
Average Score: 63%
Practice
Drugs needed for diseases with fewer than 200,000 patients, and that fail to receive attention for development because of cost and need, are called:
Correct answer
C
Rationale
The correct answer is C: orphan drugs. Orphan drugs are medications developed to treat rare diseases affecting fewer than 200,000 patients. These diseases often lack attention from pharmaceutical companies due to the high cost and limited market potential. Orphan drugs receive special incentives and regulatory support to encourage their development.
A: Secondary drugs do not specifically refer to medications for rare diseases.
B: Minor drugs is not a recognized term in the context of rare disease medications.
D: Specialty drugs typically refer to high-cost medications used to treat complex or chronic conditions, but not necessarily rare diseases.
A: Secondary drugs do not specifically refer to medications for rare diseases.
B: Minor drugs is not a recognized term in the context of rare disease medications.
D: Specialty drugs typically refer to high-cost medications used to treat complex or chronic conditions, but not necessarily rare diseases.